Search

Researchers have found that some people with chronic hepatitis C virus (HCV) in high-income countries also have mental health and substance use issues. At least ...

In this issue of TreatmentUpdate we discuss several emerging treatments for hepatitis C virus (HCV). Here is a brief guide to some drugs and the classes to ...

There are limited treatment options for patients whose previous direct-acting antivirals (DAAs) have failed to cure them of chronic hepatitis C virus (HCV) ...

People with organ transplants and hepatitis C virus (HCV) are difficult to treat because of the potential for drug-drug interactions. An advantage of ...

Hepatitis C virus (HCV) genotype 3 does not usually respond well to therapy with previously licensed direct-acting antivirals (DAAs). Therapy for this strain of ...

Most people with chronic hepatitis C virus (HCV) infection will likely be cured when they take modern all-oral treatments (otherwise known as direct-acting ...

In a study called Polaris-4, researchers enrolled participants whose previous regimen(s) of direct-acting antivirals (DAAs) had failed to cure them. Researchers ...

In late June 2017, Health Canada licensed the sale and use of a new formulation of the anti-HIV drug raltegravir (Isentress) as part of the treatment of HIV. ...

In a two-year trial called Oncemrk, researchers in Canada and other countries compared a regimen containing the older formulation of raltegravir (Isentress) to ...

A Dutch study1 found that a behavioural intervention provided by nurses that uses feedback from electronic medication monitors to improve HIV treatment (ART) adherence resulted in improved health…

This article explores what we know about getting to undetectable in Canada. However, not everyone taking ART has an undetectable viral load and this article looks at why this may be.

...